{"entity":{"type":"insider","cik":"0001649245","url":"/insider/0001649245","json_url":"/insider/0001649245.json","name":"Febbo Phillip G.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":23,"n_filings":15,"first":"2016-05-12","last":"2026-03-04","span_basis":"filed_date"},"name_variants":[{"name":"Febbo Phillip G.","source":"filing","n_filings":15,"first_seen":"2016-05-12","last_seen":"2026-03-04"}],"transactions":[{"id":6139511,"accession":"0001649245-26-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001649245-26-000004","line_url":"/filing/0001649245-26-000004#line-2","is_derivative":false,"issuer_cik":"0001384101","issuer_name":"VERACYTE, INC.","issuer_ticker":"VCYT","issuer_name_source":null,"issuer_url":"/issuer/0001384101","owner_cik":"0001649245","owner_name":"Febbo Phillip G.","owner_url":"/insider/0001649245","role":"Officer (Chief Scientific & Med Officer)","officer_title":"Chief Scientific & Med Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13425.0,"shares_display":"13,425","price_per_share":36.1586,"price_display":"36.16","price_state":"stated","total_value":485429.205,"total_display":"485,429.20","shares_owned_after":117346.0,"shares_owned_after_display":"117,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":4387894,"accession":"0001649245-25-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001649245-25-000005","line_url":"/filing/0001649245-25-000005#line-1","is_derivative":false,"issuer_cik":"0001384101","issuer_name":"VERACYTE, INC.","issuer_ticker":"VCYT","issuer_name_source":null,"issuer_url":"/issuer/0001384101","owner_cik":"0001649245","owner_name":"Febbo Phillip G.","owner_url":"/insider/0001649245","role":"Officer (Chief Scientific & Med Officer)","officer_title":"Chief Scientific & Med Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8349.0,"shares_display":"8,349","price_per_share":36.0174,"price_display":"36.02","price_state":"stated","total_value":300709.2726,"total_display":"300,709.27","shares_owned_after":92441.0,"shares_owned_after_display":"92,441","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-06","filed_date":"2025-10-07","scope":"insider"},{"id":5152098,"accession":"0001384101-25-000032","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001384101-25-000032","line_url":"/filing/0001384101-25-000032#line-2","is_derivative":false,"issuer_cik":"0001384101","issuer_name":"VERACYTE, INC.","issuer_ticker":"VCYT","issuer_name_source":null,"issuer_url":"/issuer/0001384101","owner_cik":"0001649245","owner_name":"Febbo Phillip G.","owner_url":"/insider/0001649245","role":"Officer (Chief Scientific & Med Officer)","officer_title":"Chief Scientific & Med Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4467.0,"shares_display":"4,467","price_per_share":32.8649,"price_display":"32.86","price_state":"stated","total_value":146807.5083,"total_display":"146,807.51","shares_owned_after":86110.0,"shares_owned_after_display":"86,110","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-06","scope":"insider"},{"id":5152086,"accession":"0001384101-25-000032","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001384101-25-000032","line_url":"/filing/0001384101-25-000032#line-1","is_derivative":false,"issuer_cik":"0001384101","issuer_name":"VERACYTE, INC.","issuer_ticker":"VCYT","issuer_name_source":null,"issuer_url":"/issuer/0001384101","owner_cik":"0001649245","owner_name":"Febbo Phillip G.","owner_url":"/insider/0001649245","role":"Officer (Chief Scientific & Med Officer)","officer_title":"Chief Scientific & Med Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3570.0,"shares_display":"3,570","price_per_share":33.9511,"price_display":"33.95","price_state":"stated","total_value":121205.427,"total_display":"121,205.43","shares_owned_after":82540.0,"shares_owned_after_display":"82,540","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-06","scope":"insider"},{"id":2804256,"accession":"0001384101-24-000186","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001384101-24-000186","line_url":"/filing/0001384101-24-000186#line-1","is_derivative":false,"issuer_cik":"0001384101","issuer_name":"VERACYTE, INC.","issuer_ticker":"VCYT","issuer_name_source":null,"issuer_url":"/issuer/0001384101","owner_cik":"0001649245","owner_name":"Febbo Phillip G.","owner_url":"/insider/0001649245","role":"Officer (Chief Scientific & Med Officer)","officer_title":"Chief Scientific & Med Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3934.0,"shares_display":"3,934","price_per_share":44.0893,"price_display":"44.09","price_state":"stated","total_value":173447.3062,"total_display":"173,447.31","shares_owned_after":82414.0,"shares_owned_after_display":"82,414","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-04","filed_date":"2024-12-06","scope":"insider"},{"id":6308579,"accession":"0001127602-22-011725","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-011725","line_url":"/filing/0001127602-22-011725#line-2","is_derivative":false,"issuer_cik":"0001110803","issuer_name":"ILLUMINA, INC.","issuer_ticker":"ILMN","issuer_name_source":null,"issuer_url":"/issuer/0001110803","owner_cik":"0001649245","owner_name":"Febbo Phillip G.","owner_url":"/insider/0001649245","role":"Officer (SVP Chief Medical Officer)","officer_title":"SVP Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1988.0,"shares_display":"1,988","price_per_share":360.01,"price_display":"360.01","price_state":"stated","total_value":715699.88,"total_display":"715,699.88","shares_owned_after":5774.0,"shares_owned_after_display":"5,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-06","filed_date":"2022-04-07","scope":"insider"},{"id":5469461,"accession":"0001127602-21-028723","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-21-028723","line_url":"/filing/0001127602-21-028723#line-2","is_derivative":false,"issuer_cik":"0001110803","issuer_name":"ILLUMINA, INC.","issuer_ticker":"ILMN","issuer_name_source":null,"issuer_url":"/issuer/0001110803","owner_cik":"0001649245","owner_name":"Febbo Phillip G.","owner_url":"/insider/0001649245","role":"Officer (SVP Chief Medical Officer)","officer_title":"SVP Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":406.83,"price_display":"406.83","price_state":"stated","total_value":406830.0,"total_display":"406,830.00","shares_owned_after":3015.0,"shares_owned_after_display":"3,015","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-08","filed_date":"2021-11-09","scope":"insider"},{"id":4625824,"accession":"0001127602-21-019827","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-21-019827","line_url":"/filing/0001127602-21-019827#line-3","is_derivative":false,"issuer_cik":"0001110803","issuer_name":"ILLUMINA, INC.","issuer_ticker":"ILMN","issuer_name_source":null,"issuer_url":"/issuer/0001110803","owner_cik":"0001649245","owner_name":"Febbo Phillip G.","owner_url":"/insider/0001649245","role":"Officer (SVP Chief Medical Officer)","officer_title":"SVP Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":447.65,"price_display":"447.65","price_state":"stated","total_value":179060.0,"total_display":"179,060.00","shares_owned_after":4751.0,"shares_owned_after_display":"4,751","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-11","filed_date":"2021-06-14","scope":"insider"},{"id":4625820,"accession":"0001127602-21-019827","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-21-019827","line_url":"/filing/0001127602-21-019827#line-2","is_derivative":false,"issuer_cik":"0001110803","issuer_name":"ILLUMINA, INC.","issuer_ticker":"ILMN","issuer_name_source":null,"issuer_url":"/issuer/0001110803","owner_cik":"0001649245","owner_name":"Febbo Phillip G.","owner_url":"/insider/0001649245","role":"Officer (SVP Chief Medical Officer)","officer_title":"SVP Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":310.0,"shares_display":"310","price_per_share":446.17,"price_display":"446.17","price_state":"stated","total_value":138312.7,"total_display":"138,312.70","shares_owned_after":5151.0,"shares_owned_after_display":"5,151","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-11","filed_date":"2021-06-14","scope":"insider"},{"id":4625816,"accession":"0001127602-21-019827","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-019827","line_url":"/filing/0001127602-21-019827#line-1","is_derivative":false,"issuer_cik":"0001110803","issuer_name":"ILLUMINA, INC.","issuer_ticker":"ILMN","issuer_name_source":null,"issuer_url":"/issuer/0001110803","owner_cik":"0001649245","owner_name":"Febbo Phillip G.","owner_url":"/insider/0001649245","role":"Officer (SVP Chief Medical Officer)","officer_title":"SVP Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":290.0,"shares_display":"290","price_per_share":449.02,"price_display":"449.02","price_state":"stated","total_value":130215.8,"total_display":"130,215.80","shares_owned_after":4461.0,"shares_owned_after_display":"4,461","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-11","filed_date":"2021-06-14","scope":"insider"},{"id":2704942,"accession":"0001127602-20-028496","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-20-028496","line_url":"/filing/0001127602-20-028496#line-2","is_derivative":false,"issuer_cik":"0001110803","issuer_name":"ILLUMINA, INC.","issuer_ticker":"ILMN","issuer_name_source":null,"issuer_url":"/issuer/0001110803","owner_cik":"0001649245","owner_name":"Febbo Phillip G.","owner_url":"/insider/0001649245","role":"Officer (SVP Chief Medical Officer)","officer_title":"SVP Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":155.0,"shares_display":"155","price_per_share":310.1,"price_display":"310.10","price_state":"stated","total_value":48065.5,"total_display":"48,065.50","shares_owned_after":2143.0,"shares_owned_after_display":"2,143","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-06","filed_date":"2020-11-09","scope":"insider"},{"id":2054408,"accession":"0001127602-20-014142","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-20-014142","line_url":"/filing/0001127602-20-014142#line-1","is_derivative":false,"issuer_cik":"0001110803","issuer_name":"ILLUMINA, INC.","issuer_ticker":"ILMN","issuer_name_source":null,"issuer_url":"/issuer/0001110803","owner_cik":"0001649245","owner_name":"Febbo Phillip G.","owner_url":"/insider/0001649245","role":"Officer (SVP Chief Medical Officer)","officer_title":"SVP Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":173.0,"shares_display":"173","price_per_share":300.0,"price_display":"300.00","price_state":"stated","total_value":51900.0,"total_display":"51,900.00","shares_owned_after":2490.0,"shares_owned_after_display":"2,490","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-16","filed_date":"2020-04-20","scope":"insider"},{"id":8641277,"accession":"0001127602-19-033040","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-19-033040","line_url":"/filing/0001127602-19-033040#line-1","is_derivative":false,"issuer_cik":"0001110803","issuer_name":"ILLUMINA, INC.","issuer_ticker":"ILMN","issuer_name_source":null,"issuer_url":"/issuer/0001110803","owner_cik":"0001649245","owner_name":"Febbo Phillip G.","owner_url":"/insider/0001649245","role":"Officer (SVP Chief Medical Officer)","officer_title":"SVP Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":155.0,"shares_display":"155","price_per_share":300.0,"price_display":"300.00","price_state":"stated","total_value":46500.0,"total_display":"46,500.00","shares_owned_after":1506.0,"shares_owned_after_display":"1,506","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-14","filed_date":"2019-11-18","scope":"insider"},{"id":6657709,"accession":"0001209191-18-012405","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-012405","line_url":"/filing/0001209191-18-012405#line-2","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001649245","owner_name":"Febbo Phillip G.","owner_url":"/insider/0001649245","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4642.0,"shares_display":"4,642","price_per_share":32.8059,"price_display":"32.81","price_state":"stated","total_value":152284.9878,"total_display":"152,284.99","shares_owned_after":21687.0,"shares_owned_after_display":"21,687","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-20","filed_date":"2018-02-22","scope":"insider"},{"id":6657706,"accession":"0001209191-18-012405","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-012405","line_url":"/filing/0001209191-18-012405#line-1","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001649245","owner_name":"Febbo Phillip G.","owner_url":"/insider/0001649245","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":33.35,"price_display":"33.35","price_state":"stated","total_value":10005.0,"total_display":"10,005.00","shares_owned_after":21387.0,"shares_owned_after_display":"21,387","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-20","filed_date":"2018-02-22","scope":"insider"},{"id":4908783,"accession":"0001209191-17-066649","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-066649","line_url":"/filing/0001209191-17-066649#line-3","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001649245","owner_name":"Febbo Phillip G.","owner_url":"/insider/0001649245","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":37.0,"price_display":"37.00","price_state":"stated","total_value":185000.0,"total_display":"185,000.00","shares_owned_after":18134.0,"shares_owned_after_display":"18,134","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-19","filed_date":"2017-12-20","scope":"insider"},{"id":4908776,"accession":"0001209191-17-066649","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-066649","line_url":"/filing/0001209191-17-066649#line-2","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001649245","owner_name":"Febbo Phillip G.","owner_url":"/insider/0001649245","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":334.0,"shares_display":"334","price_per_share":36.82,"price_display":"36.82","price_state":"stated","total_value":12297.88,"total_display":"12,297.88","shares_owned_after":17800.0,"shares_owned_after_display":"17,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-19","filed_date":"2017-12-20","scope":"insider"},{"id":5352462,"accession":"0001209191-17-045945","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-045945","line_url":"/filing/0001209191-17-045945#line-2","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001649245","owner_name":"Febbo Phillip G.","owner_url":"/insider/0001649245","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2844.0,"shares_display":"2,844","price_per_share":33.5654,"price_display":"33.57","price_state":"stated","total_value":95459.9976,"total_display":"95,460.00","shares_owned_after":18130.0,"shares_owned_after_display":"18,130","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-19","filed_date":"2017-07-21","scope":"insider"},{"id":5352458,"accession":"0001209191-17-045945","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-045945","line_url":"/filing/0001209191-17-045945#line-1","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001649245","owner_name":"Febbo Phillip G.","owner_url":"/insider/0001649245","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":330.0,"shares_display":"330","price_per_share":33.57,"price_display":"33.57","price_state":"stated","total_value":11078.1,"total_display":"11,078.10","shares_owned_after":17800.0,"shares_owned_after_display":"17,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-19","filed_date":"2017-07-21","scope":"insider"},{"id":4902172,"accession":"0001209191-17-012364","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-012364","line_url":"/filing/0001209191-17-012364#line-3","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001649245","owner_name":"Febbo Phillip G.","owner_url":"/insider/0001649245","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1269.0,"shares_display":"1,269","price_per_share":29.5613,"price_display":"29.56","price_state":"stated","total_value":37513.2897,"total_display":"37,513.29","shares_owned_after":21870.0,"shares_owned_after_display":"21,870","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-16","filed_date":"2017-02-17","scope":"insider"},{"id":4902168,"accession":"0001209191-17-012364","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-012364","line_url":"/filing/0001209191-17-012364#line-2","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001649245","owner_name":"Febbo Phillip G.","owner_url":"/insider/0001649245","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1226.0,"shares_display":"1,226","price_per_share":30.6289,"price_display":"30.63","price_state":"stated","total_value":37551.0314,"total_display":"37,551.03","shares_owned_after":20644.0,"shares_owned_after_display":"20,644","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-16","filed_date":"2017-02-17","scope":"insider"},{"id":2206826,"accession":"0001209191-16-119601","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-119601","line_url":"/filing/0001209191-16-119601#line-2","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001649245","owner_name":"Febbo Phillip G.","owner_url":"/insider/0001649245","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6224.0,"shares_display":"6,224","price_per_share":27.1885,"price_display":"27.19","price_state":"stated","total_value":169221.224,"total_display":"169,221.22","shares_owned_after":15113.0,"shares_owned_after_display":"15,113","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-10","filed_date":"2016-05-12","scope":"insider"},{"id":2206822,"accession":"0001209191-16-119601","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-119601","line_url":"/filing/0001209191-16-119601#line-1","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001649245","owner_name":"Febbo Phillip G.","owner_url":"/insider/0001649245","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":28.13,"price_display":"28.13","price_state":"stated","total_value":2813.0,"total_display":"2,813.00","shares_owned_after":15013.0,"shares_owned_after_display":"15,013","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-10","filed_date":"2016-05-12","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":23,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":23,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":23},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001384101","name":"VERACYTE, INC.","url":"/issuer/0001384101","role":"Officer (Chief Scientific & Med Officer)","n_filings":4,"first_seen":"2024-12-06","last_seen":"2026-03-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001110803","name":"ILLUMINA, INC.","url":"/issuer/0001110803","role":"Officer (SVP Chief Medical Officer)","n_filings":6,"first_seen":"2019-11-18","last_seen":"2022-04-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001131324","name":"GENOMIC HEALTH INC","url":"/issuer/0001131324","role":"Officer (Chief Medical Officer)","n_filings":5,"first_seen":"2016-05-12","last_seen":"2018-02-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001649245","retrieved_at":"2026-08-21T19:26:20+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}